KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Cash & Equivalents (2016 - 2026)

Staar Surgical's Cash & Equivalents history spans 17 years, with the latest figure at $153.2 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 6.24% year-over-year to $153.2 million; the TTM value through Jan 2026 reached $153.2 million, up 6.24%, while the annual FY2026 figure was $153.2 million, 6.24% up from the prior year.
  • Cash & Equivalents reached $153.2 million in Q1 2026 per STAA's latest filing, down from $176.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $224.0 million in Q1 2024 to a low of $86.5 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $156.3 million, with a median of $165.6 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: plummeted 56.7% in 2022, then skyrocketed 149.0% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $86.5 million in 2022, then skyrocketed by 111.65% to $183.0 million in 2023, then decreased by 21.24% to $144.2 million in 2024, then grew by 22.19% to $176.2 million in 2025, then decreased by 13.06% to $153.2 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Cash & Equivalents are $153.2 million (Q1 2026), $176.2 million (Q3 2025), and $167.1 million (Q2 2025).